Wenjie Shi
No.300 Guangzhou Road
Nanjing, 210000, China
Nanjing, 210000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Polyamine-related 4-gene prognostic signature in hepatocellular carcinoma.
Journal: Medicine
Published: March 09, 2026
Novel insights into triple-negative breast cancer heterogeneity, prognosis, and treatment response based on matrix stiffness: a combined single-Cell and transcriptome analysis.
Journal: Frontiers in oncology
Published: March 04, 2026
Radiomic imaging models for predicting breast cancer prognosis based on Interleukin-18 (IL18).
Journal: BMC medical imaging
Published: July 01, 2025
Nomogram Based on the Dynamic Change in the Neutrophil-to-Lymphocyte Ratio for Predicting the Pathological Complete Response of Breast Cancer after Neoadjuvant Systemic Therapy.
Journal: Oncology research and treatment
Published: October 05, 2024
Development and validation of a combined ultrasound-pathology model to predict axillary status after neoadjuvant systemic therapy in breast cancer.
Journal: International journal of medical sciences
Published: August 03, 2024
Construction and application of clinical nursing intern teaching system from the perspective of educational ecology: A quasi-experiment study.
Journal: Medicine
Published: May 10, 2024
Exploring optimal administration timing of pegylated recombinant human granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in early breast cancer treated with pharmorubicin and endoxan: a prospective randomized controlled clinical trial.
Journal: BMC cancer
Published: April 05, 2024
A 3'-pre-tRNA-derived small RNA tRF-1-Ser regulated by 25(OH)D promotes proliferation and stemness by inhibiting the function of MBNL1 in breast cancer.
Journal: Clinical and translational medicine
Published: January 19, 2024
Efficacy comparisons of solvent-based paclitaxel, liposomal paclitaxel, nanoparticle albumin-bound paclitaxel, and docetaxel after neoadjuvant systemic treatment in breast cancer.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: April 25, 2023
Comparison of clinicopathological characteristics and response to neoadjuvant systemic therapy in patients with HER2-low-positive and HER2-zero breast cancer.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Published: January 19, 2023
Nanoparticle albumin-bound paclitaxel-based neoadjuvant regimen: A promising treatment option for HER2-low-positive breast cancer.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: December 28, 2022
Corrigendum: A novel nomogram containing efficacy indicators to predict axillary pathologic complete response after neoadjuvant systemic therapy in breast cancer.
Journal: Frontiers in endocrinology
Published: November 27, 2022
Last Updated: 09/26/2026